Microsomal	JJ
prostaglandin	NN
E	NN
synthase-1	NN
deficiency	NN
exacerbates	VBZ
pulmonary	JJ
fibrosis	NN
induced	VBN
by	IN
bleomycin	NN
in	IN
mice	NNS
.	.

Microsomal	JJ
prostaglandin	NN
E2	NN
synthase-1	NN
(	(
mPGES-1	NN
)	)
,	,
an	DT
inducible	JJ
enzyme	NN
that	WDT
converts	VBZ
prostaglandin	NN
H2	NN
(	(
PGH2	NN
)	)
to	TO
prostaglandin	NN
E2	NN
(	(
PGE2	NN
)	)
,	,
plays	VBZ
an	DT
important	JJ
role	NN
in	IN
a	DT
variety	NN
of	IN
diseases	NNS
.	.

So	RB
far	RB
,	,
the	DT
role	NN
of	IN
mPGES-1	NN
in	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
remained	VBD
unknown	JJ
.	.

The	DT
current	JJ
study	NN
aimed	VBN
to	TO
investigate	VB
the	DT
role	NN
of	IN
mPGES-1	NN
in	IN
pulmonary	JJ
fibrosis	NN
induced	VBN
by	IN
bleomycin	NN
in	IN
mice	NNS
.	.

We	PRP
found	VBD
that	IN
mPGES-1	NN
deficient	JJ
(	(
mPGES-1	NN
-	:
/	:
-	:
)	)
mice	NNS
exhibited	VBD
more	RBR
severe	JJ
fibrotic	JJ
lesions	NNS
with	IN
a	DT
decrease	NN
in	IN
PGE2	NN
content	NN
in	IN
lungs	NNS
after	IN
bleomycin	NN
treatment	NN
when	WRB
compared	VBN
with	IN
wild	JJ
type	NN
(	(
mPGES-1	NN
+	CC
/	:
+	CC
)	)
mice	NNS
.	.

The	DT
mPGES-1	NN
expression	NN
levels	NNS
and	CC
PGE2	NN
content	NN
were	VBD
also	RB
decreased	VBN
in	IN
bleomycin-treated	JJ
mPGES-1	NN
+	CC
/	:
+	CC
mice	NNS
compared	VBN
to	TO
saline-treated	JJ
mPGES-1	NN
+	CC
/	:
+	CC
mice	NNS
.	.

Moreover	RB
,	,
in	IN
both	DT
mPGES-1	NN
-	:
/	:
-	:
and	CC
mPGES-1	NN
+	CC
/	:
+	CC
mice	NNS
,	,
bleomycin	NN
treatment	NN
reduced	VBD
the	DT
expression	NN
levels	NNS
of	IN
E	NN
prostanoid	NN
receptor	NN
2	CD
(	(
EP2	NN
)	)
and	CC
EP4	NN
receptor	NN
in	IN
lungs	NNS
,	,
whereas	IN
had	VBD
little	JJ
effect	NN
on	IN
EP1	NN
and	CC
EP3	NN
.	.

In	IN
cultured	VBN
human	JJ
lung	NN
fibroblast	NN
cells	NNS
(	(
MRC-5	NN
)	)
,	,
siRNA-mediated	JJ
knockdown	NN
of	IN
mPGES-1	NN
augmented	VBD
transforming-growth-factor-b1	NN
(	(
TGF-b1	NN
)	)
-	:
induced	VBN
a-smooth-muscle-actin	NN
(	(
a-SMA	NN
)	)
protein	NN
expression	NN
,	,
and	CC
the	DT
increase	NN
was	VBD
reversed	VBN
by	IN
treatment	NN
of	IN
PGE2	NN
,	,
selective	JJ
EP2	NN
agonist	NN
and	CC
focal-adhesion-kinase	NN
(	(
FAK	NN
)	)
inhibitor	NN
.	.

In	IN
conclusion	NN
,	,
these	DT
findings	NNS
revealed	VBD
mPGES-1	NN
exerts	VBZ
an	DT
essential	JJ
effect	NN
against	IN
pulmonary	JJ
fibrogenesis	NN
via	IN
EP2-mediated	JJ
signaling	NN
transduction	NN
,	,
and	CC
activation	NN
of	IN
mPGES-1-PGE2-EP2-FAK	NN
signaling	NN
pathway	NN
may	MD
represent	VB
a	DT
new	JJ
therapeutic	JJ
strategy	NN
for	IN
treatment	NN
of	IN
IPF	NN
patients	NNS
.	.

